"In Anderson, Indiana, Ascension St. Vincent Anderson - Hospital and ER is a critical care hospital with advanced specialty care services."

During the past decade, Ascension Saint Vincent Anderson conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Saint Vincent Anderson" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Jeffrey Clarke" with 1 trials sponsored, "NRG Oncology" with 1 trials sponsored and "Nasser Hanna, M.D." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Saint Vincent Anderson" #1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Saint Vincent Anderson" are "Breast Adenocarcinoma" (2 trials), "Stage IA Breast Cancer AJCC v7" (2 trials), "Stage IB Breast Cancer AJCC v7" (2 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (2 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Ascension Saint Vincent Anderson" in a lesser frequency.

Most popular intervention types in "Ascension Saint Vincent Anderson" are "Drug" (8 trials), "Other" (6 trials), "Biological" (5 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (5 trials), "Docetaxel" (4 trials), "Cyclophosphamide" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Saint Vincent Anderson" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ascension Saint Vincent Anderson". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ascension Saint Vincent Anderson, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Saint Vincent Anderson, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".